Sector
PharmaceuticalsOpen
₹603.4Prev. Close
₹600.4Turnover(Lac.)
₹5.49Day's High
₹604Day's Low
₹59452 Week's High
₹99952 Week's Low
₹567.15Book Value
₹563.58Face Value
₹10Mkt Cap (₹ Cr.)
212.56P/E
8.6EPS
69.27Divi. Yield
022 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
19 Aug 2024
12:00 AM
AGM
Announcement Date: 19 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3.57 | 3.57 | 3.57 | 3.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 173.92 | 151.23 | 152.48 | 133.07 |
Net Worth | 177.49 | 154.8 | 156.05 | 136.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 96.56 | 70.57 | 92.47 | 95.47 |
yoy growth (%) | 36.82 | -23.67 | -3.13 | 23.96 |
Raw materials | -50.06 | -40.02 | -53.57 | -48.67 |
As % of sales | 51.84 | 56.71 | 57.93 | 50.98 |
Employee costs | -10.18 | -9.7 | -8.56 | -6.75 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 17.59 | 9.11 | 18.04 | 24.88 |
Depreciation | -1.98 | -2 | -1.56 | -1.55 |
Tax paid | -4.05 | -1.98 | -5.6 | -8.26 |
Working capital | 11.57 | 22.79 | -3.33 | 10.21 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.82 | -23.67 | -3.13 | 23.96 |
Op profit growth | 199.58 | -65.14 | -34.33 | 41.59 |
EBIT growth | 92.21 | -49.25 | -27.44 | 42.53 |
Net profit growth | 90.09 | -42.7 | -23.62 | 31.45 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672.5 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,833.1 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485.05 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,313.15 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Girish Dhameja
Director & CFO
Sushma Shashi Kadkade
Independent Director
Saurabh Shah
Independent Director
Malay Doshi
Non Executive Director
Rajendrasinh Rana
Company Sec. & Compli. Officer
Dhwani Desai
Independent Director
Pooja Hindia
SF-206 Silver Oak Complex,
BPC Road,
Gujarat - 390020
Tel: 91-022-2500 5245/46
Website: http://www.corallab.com
Email: cs@corallab.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmac...
Read More
Reports by Coral Laboratories Ltd
What is the Coral Laboratories Ltd share price today?
What is the Market Cap of Coral Laboratories Ltd?
What is the PE and PB ratio of Coral Laboratories Ltd?
What is the 52 Week High and Low of Coral Laboratories Ltd?
What is the CAGR of Coral Laboratories Ltd?
What is the shareholding pattern of Coral Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.